Adopting an end-to-end commercial content management system has allowed one of the world’s biggest pharmaceutical companies to be quicker, more efficient and more compliant.
Bavarian Nordic is preparing to file for regulatory approval of a vaccine against chikungunya virus after its CHIKV VLP candidate showed protective efficacy in a second ph
To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to metho